GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Crism Therapeutics Corp (LSE:CRTX) » Definitions » Purchase Of Business

Crism Therapeutics (LSE:CRTX) Purchase Of Business : £0.00 Mil (TTM As of Jun. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Crism Therapeutics Purchase Of Business?

Crism Therapeutics's purchase of business for the six months ended in Jun. 2024 was £0.00 Mil. It means Crism Therapeutics spent £0.00 Mil on purchasing business. Crism Therapeutics's purchase of business for the trailing twelve months (TTM) ended in Jun. 2024 was £0.00 Mil.

Compared with last quarter (£0.00 Mil in Dec. 2023 ), Crism Therapeutics spent the same money on purchasing business in Jun. 2024 (£0.00 Mil).

Crism Therapeutics Purchase Of Business Historical Data

The historical data trend for Crism Therapeutics's Purchase Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Crism Therapeutics Purchase Of Business Chart

Crism Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Purchase Of Business
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Crism Therapeutics Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Purchase Of Business Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Crism Therapeutics Purchase Of Business Calculation

The amount used to purchase business.

Purchase Of Business for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Crism Therapeutics Purchase Of Business Related Terms

Thank you for viewing the detailed overview of Crism Therapeutics's Purchase Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.

Crism Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Crism Therapeutics Corp (LSE:CRTX) » Definitions » Purchase Of Business
Comparable Companies
LSE:ROQ LSE:BSFA LSE:GENF LSE:NFX LSE:VAL LSE:TCF LSE:PYC LSE:ONC LSE:APTA LSE:CIZ VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
Kingston Chambers, P.O. Box 173, Tortola, Road Town, VGB
Website
https://www.crismtherapeutics.com
Crism Therapeutics Corp has developed a drug delivery technology to improve the clinical performance of cancer treatments for solid tumours through the local delivery of chemotherapy drugs. Its product ChemoSeed which is in its clinical trial phase, can be implanted directly into the tumour or the resection margin following the removal of a tumour. The company also provides consultancy and formulation services to its clients assisting them with pharmaceutical formulation and development.

Crism Therapeutics Headlines

No Headlines